Logo
x

Search

Subscribe Now

Parkinson Disease

Ipsen Signs an Exclusive WW License Agreement with IRLAB for Mesdopetam to Treat Parkinson Disease

Ipsen Signs an Exclusive WW License Agreement with IRLAB for Mesdopetam to Treat Parkinson Disease

  • July 16, 2021
Voyager Therapeutics Provides Update on NBIB-1817 (VY-AADC) Program to Treat Parkinson Disease

Voyager Therapeutics Provides Update on NBIB-1817 (VY-AADC) Program to Treat Parkinson Disease

  • December 23, 2020
Roche and Prothena to Advance Prasinezumab in P-IIb Study for Patients with Early Parkinson's Disease

Roche and Prothena to Advance Prasinezumab in P-IIb Study for Patients with Early Parkinson's Disease

  • October 21, 2020
Neurocrine Presents New Data Analyses of Ongentys (opicapone) for Parkinson Disease at ANA 2020 Virtual Meeting

Neurocrine Presents New Data Analyses of Ongentys (opicapone) for Parkinson Disease at ANA 2020 Virtual Meeting

  • September 28, 2020
Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant to Manufacture and Supply AXO-Lenti-PD for Parkinson's Disease

Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant to Manufacture and Supply AXO-Lenti-PD for Parkinson's Di...

  • July 31, 2020
Sunovion Pharmaceutical's Kynmobi (apomorphine hydrochloride) Receives the US FDA's Approval to Treat Parkinson's Disease Off Episodes

Sunovion Pharmaceutical's Kynmobi (apomorphine hydrochloride) Receives the US FDA's Approval to Treat Parkinson's Disease Off Epis...

  • May 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.